CardioGenesis adds platelet prep tech to portfolio:
This article was originally published in Clinica
Executive Summary
CardioGenesis plans to launch this month a product for preparing autologous platelet rich plasma in point of care (POC) settings. The CelleratOR, which represents the firm's first new product beyond laser myocardial revascularisation devices, is designed for use in surgical suites. It consists of a small centrifuge system and proprietary disposables to prepare the platelet concentrate from the patient's blood sample; the concentration level can be determined by the physician at the time of preparation. Compared with competitive systems, the Foothill Ranch, California firm claims that CelleratOR provides the advantage of scalability. In a separate announcement, CardioGenesis said it had gained US market approval for its SolarGen 2100s product, an advanced laser console for performing surgical heart laser therapy.